Hospital-acquired pneumonia: microbiological data and potential adequacy of antimicrobial regimens

Leroy O., Giradie P., Yazdanpanah Y., Georges H., Alfandari S., Sanders V., Devos P., Beaucaire G.

Source: Eur Respir J 2002; 20: 432-439
Journal Issue: August
Disease area: Respiratory critical care, Respiratory infections

Congress or journal article abstractPDF journal article, handout or slidesFull text journal article

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Leroy O., Giradie P., Yazdanpanah Y., Georges H., Alfandari S., Sanders V., Devos P., Beaucaire G.. Hospital-acquired pneumonia: microbiological data and potential adequacy of antimicrobial regimens. Eur Respir J 2002; 20: 432-439

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Importance of appropriate initial antibiotic therapy and de-escalation in the treatment of nosocomial pneumonia
Source: Eur Respir Rev 2007; 16: 33-39
Year: 2007



VAP: approach to therapy
Source: Eur Respir Mon 2011; 53: 36-47
Year: 2011


Pharmacokinetic optimisation of β-lactams for the treatment of ventilator-associated pneumonia
Source: Eur Respir Rev 2007; 16: 45-49
Year: 2007



Antibiotic treatment for nosocomial pneumonia
Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=211
Year: 2004

Determinants of prescription and choice of empirical therapy for hospital-acquired and ventilator-associated pneumonia
Source: Eur Respir J 2011; 37: 1332-1339
Year: 2011



Cost-effective antibiotic management of community acquired pneumonia
Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=198
Year: 2004

Appropriateness and delay to initiate therapy in ventilator-associated pneumonia
Source: Eur Respir J 2006; 27: 158-164
Year: 2006



Optimising the duration of antibiotic therapy for ventilator-associated pneumonia
Source: Eur Respir Rev 2007; 16: 40-44
Year: 2007



Relevance of correct antibiotic choice in community-acquired pneumonia (CAP)
Source: Annual Congress 2005 - Community-acquired pneumonia: clinical approaches
Year: 2005


Ventilator-associated pneumonia due to colistin susceptible-only microorganisms
Source: Eur Respir J 2007; 30: 307-313
Year: 2007



Guideline-concordant therapy and outcomes in healthcare-associated pneumonia
Source: Eur Respir J 2011; 38: 878-887
Year: 2011



Antibiotic use
Source: Annual Congress 2005 - Protocols in the critically ill patient
Year: 2005

The approach to antibiotic treatment in community-acquired pneumonia
Source: Annual Congress 2008 - MP14 - The approach to antibiotic treatment in community-acquired pneumonia
Year: 2008

Impact of macrolide therapy on mortality for patients with severe sepsis due to pneumonia
Source: Eur Respir J 2009; 33: 153-159
Year: 2009



Diagnosis and treatment of nosocomial pneumonia in ALI/ARDS patients
Source: Eur Respir J 2003; 22: 77S-83S
Year: 2003



Duration of antibiotic therapy in hospitalised patients with community-acquired pneumonia
Source: Eur Respir J 2010; 36: 128-134
Year: 2010



Hospital-acquired pneumonia: coverage and treatment adequacy of current guidelines
Source: Eur Respir J 2003 Dec 01;22(6):876-882
Year: 2003



Antibacterial class is not obviously important in outpatient pneumonia: a meta-analysis
Source: Eur Respir J 2008; 31: 1068-1076
Year: 2008



Aspiration risks factors, microbiology and empiric antibiotics for patients hospitalized with community-acquired pneumonia
Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice
Year: 2020


Emergency treatment of communityacquired pneumonia
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-42-1, page=183
Year: 2006